(Q34506168)

2 August 2017

title

MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer (English)

1 reference

2 August 2017

Cuevas BD

1

1 reference

2 August 2017

Winter-Vann AM

series ordinal

2

1 reference

2 August 2017

Johnson NL

series ordinal

3

1 reference

2 August 2017

Johnson GL

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

27 March 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

25

1 reference

2 August 2017

issue

36

1 reference

2 August 2017

page(s)

4998-5010

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209507

2 August 2017

exact match

0 references

cites work

Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Axis of evil: molecular mechanisms of cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Evidence for the clinical use of tumour markers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

7th Jan Waldenström Lecture. The biology of human cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Metabolic mapping of proteinase activity with emphasis on in situ zymography of gelatinases: review and protocols

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

MAP kinases and cell migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

JNK phosphorylates paxillin and regulates cell migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

AP-1 function and regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

The loss of estrogen and progesterone receptor gene expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Matrix metalloproteinases in tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Upregulation of bikunin in tumor-infiltrating macrophages as a factor of favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Regulation of matrix metalloproteinase expression in tumor invasion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

MEKK1 is required for inducible urokinase-type plasminogen activator expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209507

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209507

1 reference

Dimensions Publication ID

2 August 2017

1051984566

0 references

1 reference